文献速递慢性静脉疾病静脉血栓栓塞

自膨式静脉支架治疗髂股静脉流出道梗阻的临床结局

Clinical outcomes of venous self-expanding stent placement for iliofemoral venous outflow obstruction.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-02-04

本回顾性研究纳入49例接受Zilver Vena自膨式支架治疗的髂股静脉梗阻患者,包括急性深静脉血栓19例、非血栓性髂静脉病变7例和血栓后综合征23例。术后1年一期、辅助一期和二期通畅率分别为93.8%、95.9%和97.9%,Villalta评分和VCSS评分均较基线改善。结论认为该支架1年通畅率优异且改善临床结局。

要点

  • Zilver Vena支架治疗髂股静脉梗阻1年一期通畅率93.8%。
  • 血栓后综合征患者Villalta评分中位数从19降至4.0。
  • 术后VCSS中位数从11降至3.0,症状显著改善。

核心结论

  • 自膨式静脉支架置入对急性深静脉血栓、非血栓性髂静脉病变和血栓后综合征所致髂股静脉梗阻提供优异的1年通畅率并改善结局。

研究设计与样本

  • 回顾性研究纳入49例2017年9月至2019年3月接受Zilver Vena支架治疗的髂股静脉梗阻患者,均行随访双功超声评估支架通畅性。

主要发现

  • 49例中急性深静脉血栓19例、非血栓性髂静脉病变7例、血栓后综合征23例。
  • 术后1年一期、辅助一期和二期通畅率分别为93.8%、95.9%和97.9%。
  • 血栓后综合征患者基线Villalta评分中位数19(范围11-30),术后1年降至4.0(范围2-18)。
  • 血栓后综合征和非血栓性髂静脉病变患者基线VCSS中位数11(范围6-25),术后1年降至3.0(范围2-12)。

临床怎么用

  • 对于髂股静脉流出道梗阻(急性深静脉血栓、非血栓性髂静脉病变、血栓后综合征),可考虑使用Zilver Vena自膨式支架,术后1年通畅率和症状改善良好。

局限性

  • 回顾性设计、样本量较小(49例)、随访仅1年,缺乏对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In the present study, we evaluated the feasibility of a self-expanding venous stent for treating iliofemoral venous obstruction. METHODS: The present retrospective study reviewed the data from 49 patients who had undergone Zilver Vena (Cook Medical, Bloomington, Ind) stent placement for treatment of iliofemoral venous obstruction from September 2017 to March 2019. All patients had undergone received follow-up duplex ultrasound examinations to assess for stent patency. The Villalta scores and Venous Clinical Severity Scores (VCSSs) were also calculated to stratify the postoperative improvement in disease. RESULTS: Of the 49 patients, 19 had had acute deep vein thrombosis, 7, nonthrombotic iliac venous lesions, and 23, post-thrombotic syndrome. At 1 year after Zilver Vena stent placement, the primary, assisted primary, and secondary patency rates were 93.8%, 95.9%, and 97.9%, respectively. The baseline median Villalta score before treatment for those with post-thrombotic syndrome was 19 (range, 11-30), and the median VCSS for the patients with post-thrombotic syndrome and nonthrombotic iliac venous lesions was 11 (range, 6-25). At 1 year after stent placement, the median Villalta score for the post-thrombotic syndrome patients was 4.0 (range, 2-18), and the median VCSS for the post-thrombotic syndrome and nonthrombotic iliac venous lesions patients was 3.0 (range, 2-12). CONCLUSIONS: Venous placement of self-expanding stents offers excellent 1-year patency rates and improved the outcomes of patients with iliofemoral venous obstruction caused by acute deep vein thrombosis, nonthrombotic iliac venous lesions, and post-thrombotic syndrome.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Xu H, Tian Y, Zhang J, et al. Clinical outcomes of venous self-expanding stent placement for iliofemoral venous outflow obstruction. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33548554. doi:10.1016/j.jvsv.2021.01.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。